Randomized Controlled Trial of Interventions for Young People at Ultra High Risk for Psychosis: 6-Month Analysis
The DOI matches its Crossref record.
Abstract
OBJECTIVE: Cognitive therapy and/or low-dose antipsychotic administered during the prodromal phase of schizophrenia may prevent or delay the onset of full-blown illness. However, it is unclear which of these treatments are most effective, how long treatment should be given, and whether effects will be sustained over a prolonged period. METHOD: In order to examine these issues, we conducted a randomized controlled trial of cognitive therapy + risperidone; cognitive therapy + placebo; and supportive therapy + placebo in young people at ultra high risk for developing a psychotic disorder (that is, putatively prodromal). The main outcome was transition to psychotic disorder, with level of symptoms and functioning the secondary outcomes. This article reports the interim 6-month follow-up results. The study was conducted from August 2000 to May 2007. RESULTS: Of a possible 464 eligible ultra high risk individuals, 115 were recruited to the randomized controlled trial (cognitive therapy + risperidone, n = 43; cognitive therapy + placebo, n = 44; and supportive therapy + placebo, n = 28). An additional 78 individuals agreed to follow-up assessments but not to randomization ("monitoring group," n = 78). At 6 months, 8 of the 115 participants (7.0%) and 4 of the monitoring group (5.1%) had developed psychotic disorder. There were no significant differences between the 3 randomized groups (log rank test, P = .92) or between all 4 groups (log rank test, P = .93). There was also no difference between the 4 groups in secondary measures, with all groups showing a reduction in symptoms and increased functioning. CONCLUSIONS: Rates of transition to psychosis were lower than expected, particularly in the control supportive therapy + placebo group. This may have accounted for the negative finding, as the sample was therefore underpowered to find any difference between groups. Alternatively, it may be that all treatments were equally effective or equally ineffective at 6 months. TRIAL REGISTRATION: http://www.anzctr.org.au Identifier: ACTRN012605000247673.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
The Psychosis High-Risk State: A Comprehensive State-of-the-Art Review
Fusar-Poli, P., Borgwardt, S., Bechdolf, A., Addington, J., Riecher-Rössler, A., Schultze-Lutter, F., Keshavan, M., Wood, S., Ruhrmann, S., Seidman, L. J., et al. (2013) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.269 · Cited by 1,483
Self-citationBarnes, T. R., Drake, R., Paton, C., Cooper, S. J., Deakin, B., Ferrier, I. N., Gregory, C. J., Haddad, P. M., Howes, O. D., Jones, I., et al. (2020) · Journal of Psychopharmacology · doi:10.1177/0269881119889296 · Cited by 606
Self-citationEPA guidance on the early intervention in clinical high risk states of psychoses
Schmidt, S. J., Schultze-Lutter, F., Schimmelmann, B. G., Maric, N. P., Salokangas, R. K. R., Riecher-Rössler, A., van der Gaag, M., Meneghelli, A., Nordentoft, M., Marshall, M., et al. (2015) · European Psychiatry · doi:10.1016/j.eurpsy.2015.01.013 · Cited by 585
“…(2 0 1 5 ) 3 8 8 – 4 0 4 3 9 4 Table 1 (Continued ) Pharmacological studies – combined with psychological interventions – (MED) McGorry et al., 2013 [69]; Yung et al., 2011 [128]; GE 1 AUS RCT Inclusion criteria: age 14–30 years; Melbourne metropolitan area; risk for psychosis (CAARMS 2006), UHR…”
BackgroundEarly interventions to prevent psychosis: systematic review and meta-analysis
Stafford, M. R., Jackson, H., Mayo-Wilson, E., Morrison, A. P., & Kendall, T. (2013) · BMJ · doi:10.1136/bmj.f185 · Cited by 456
Long-term Follow-up of a Group at Ultra High Risk (“Prodromal”) for Psychosis: The PACE 400 Study
Nelson, B., Yuen, H. P., Wood, S. J., Lin, A., Spiliotacopoulos, D., Bruxner, A., Broussard, C., Simmons, M., Foley, D. L., Brewer, W. J., et al. (2013) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.1270 · Cited by 433
Self-citationvan der Gaag, M., Smit, F., Bechdolf, A., French, P., Linszen, D. H., Yung, A. R., McGorry, P., & Cuijpers, P. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.07.004 · Cited by 384
“Three studies intervened with antipsychotic medication: an older Australian study (McGorry et al., 2002; Phillips et al., 2007) a recent Australian study (Yung et al., 2011; McGorry et al., 2013) and the American PRIME study (McGlashan et al., 2006).”
BackgroundSelf-citationMorrison, A. P., French, P., Stewart, S. L. K., Birchwood, M., Fowler, D., Gumley, A. I., Jones, P. B., Bentall, R. P., Lewis, S. W., Murray, G. K., et al. (2012) · BMJ · doi:10.1136/bmj.e2233 · Cited by 332
Psychotic Symptoms and Population Risk for Suicide Attempt: A Prospective Cohort Study
Kelleher, I., Corcoran, P., Keeley, H., Wigman, J. T. W., Devlin, N., Ramsay, H., Wasserman, C., Carli, V., Sarchiapone, M., Hoven, C., et al. (2013) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.140 · Cited by 252
Lack of evidence to favor specific preventive interventions in psychosis: a network meta‐analysis
Davies, C., Cipriani, A., Ioannidis, J. P. A., Radua, J., Stahl, D., Provenzani, U., McGuire, P., & Fusar‐Poli, P. (2018) · World Psychiatry · doi:10.1002/wps.20526 · Cited by 229
van der Gaag, M., Nieman, D. H., Rietdijk, J., Dragt, S., Ising, H. K., Klaassen, R. M. C., Koeter, M., Cuijpers, P., Wunderink, L., & Linszen, D. H. (2012) · Schizophrenia Bulletin · doi:10.1093/schbul/sbs105 · Cited by 209
Miklowitz, D. J., O’Brien, M. P., Schlosser, D. A., Addington, J., Candan, K. A., Marshall, C., Domingues, I., Walsh, B. C., Zinberg, J. L., De Silva, S. D., et al. (2014) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2014.04.020 · Cited by 200
Prediction and Prevention of Psychosis in Youth at Clinical High Risk
Addington, J., & Heinssen, R. (2012) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-032511-143146 · Cited by 189
“Only one study to date has been designed to explore whether pharmacological or psychological treatments alone or in combination are effective treatments for young people at risk for psychosis (Phillips et al. 2009, Yung et al. 2011).”
BackgroundInfluentialCognitive behavioural therapy for psychosis prevention: a systematic review and meta-analysis
Hutton, P., & Taylor, P. J. (2014) · Psychological Medicine · doi:10.1017/s0033291713000354 · Cited by 184
“03) if we excluded equivocal data from (Yung et al., 2011).”
BackgroundMei, C., van der Gaag, M., Nelson, B., Smit, F., Yuen, H. P., Berger, M., Krcmar, M., French, P., Amminger, G. P., Bechdolf, A., et al. (2021) · Clinical Psychology Review · doi:10.1016/j.cpr.2021.102005 · Cited by 143
Self-citationPreventive Treatments for Psychosis: Umbrella Review (Just the Evidence)
Fusar-Poli, P., Davies, C., Solmi, M., Brondino, N., De Micheli, A., Kotlicka-Antczak, M., Shin, J. I., & Radua, J. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00764 · Cited by 108
Davies, C., Radua, J., Cipriani, A., Stahl, D., Provenzani, U., McGuire, P., & Fusar-Poli, P. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00187 · Cited by 107
Hartmann, J. A., Yuen, H. P., McGorry, P. D., Yung, A. R., Lin, A., Wood, S. J., Lavoie, S., & Nelson, B. (2016) · Schizophrenia Research · doi:10.1016/j.schres.2015.11.026 · Cited by 106
“…the UHRspecialized PACE Clinic (Melbourne, Australia) and participating in one of seven research studies (Berger et al., 2012; McGorry et al., 2002; Phillips et al., 2009; Thompson et al., 2007; Yung et al., 1996; Yung et al., 2011; Yung et al., 2003) conducted between 1995 and 2006 in this centre.”
BackgroundMethodHui, C., Morcillo, C., Russo, D. A., Stochl, J., Shelley, G. F., Painter, M., Jones, P. B., & Perez, J. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.05.026 · Cited by 96
Fisher, M., Loewy, R., Hardy, K., Schlosser, D., & Vinogradov, S. (2013) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-032511-143134 · Cited by 71
“McGorry et al. (2002) and Yung et al. (2011) both examined CT combined with an antipsychotic medication, although Yung and colleagues (2011) included a CT-plus-placebo group.”
BackgroundResultInfluentialZanini, M., Castro, J., Coelho, F. M., Bittencourt, L., Bressan, R. A., Tufik, S., & Brietzke, E. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.08.012 · Cited by 69
New Targets for Prevention of Schizophrenia: Is It Time for Interventions in the Premorbid Phase?
Seidman, L. J., & Nordentoft, M. (2015) · Schizophrenia Bulletin · doi:10.1093/schbul/sbv050 · Cited by 65
Pathways to psychosis: Help-seeking behavior in the prodromal phase
Rietdijk, J., Hogerzeil, S. J., van Hemert, A. M., Cuijpers, P., Linszen, D. H., & van der Gaag, M. (2011) · Schizophrenia Research · doi:10.1016/j.schres.2011.08.009 · Cited by 64
Byrne, R. E., & Morrison, A. P. (2014) · Psychology and Psychotherapy: Theory, Research and Practice · doi:10.1111/papt.12013 · Cited by 23
Morita, K., Kobayashi, H., Takeshi, K., Tsujino, N., Nemoto, T., & Mizuno, M. (2014) · Early Intervention in Psychiatry · doi:10.1111/eip.12032 · Cited by 16
Metadata
- Authors
- Yung, A. R., Phillips, L. J., Nelson, B., Francey, S. M., PanYuen, H., Simmons, M. B., Ross, M. L., Kelly, D., Baker, K., Amminger, G. P., Berger, G., Thompson, A. D., Thampi, A., & McGorry, P. D.
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2010-10-19
- Volume
- 72
- Issue
- 04
- Pages
- 430-440
- ISSN
- 0160-6689 (ISSN-L)
- OpenAlex
- W2065826711
- Cited by
- 146
- References
- 0
- FWCI
- 11.96
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.